These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1805499)

  • 21. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
    Joó I
    Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 24. [Identification of specific antibodies in dysentery].
    Bunin KV; Belaia OF
    Sov Med; 1984; (10):19-22. PubMed ID: 6393359
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enteric dysentery vaccines and their effectiveness in a rabbit intestinal loop model. I. The residual virulence of attenuated vaccinal strains of Shigella administered into the intestinal loops].
    Polotskiĭ IuE; Fedotova IuM; Rukhamina ML; Seliverstova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):32-6. PubMed ID: 7004003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N; Robin G; Cohen D; Arnon R; Lowell GH
    Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
    Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
    Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
    [No Abstract]   [Full Text] [Related]  

  • 30. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of S.sonnei form I antigen gene and V.cholerae toxin B subunit gene in S.flexneri 2a strain and investigation of their immunoprotective response in mice].
    Qian F; Rui X; Su G; Huang C
    Yi Chuan Xue Bao; 1996; 23(4):322-8. PubMed ID: 8950856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
    Levine MM; Gangarosa EJ; Werner M; Morris GK
    J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral vaccination using live, apathogenic nondependent Shigella organisms].
    Meitert T; Istrati G; Ciufecu C; Sulea IT
    Z Gesamte Hyg; 1972 Oct; 18(10):753-6. PubMed ID: 4581672
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shigella flexneri 2a and sonnei I vaccine with two attenuating markers: construction, tolerability and immunogenicity in 143 children aged 3-17 years.
    Linde K; Randhagen B; Beer J; Dentchev V; Marinova S; Vassilev T; Bratoyeva M
    Vaccine; 1993; 11(2):197-9. PubMed ID: 8438618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization against dysentery.
    Kétyi I; Rauss K; Vertényi A
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
    mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
    [No Abstract]   [Full Text] [Related]  

  • 39. [Live vaccines for the prevention of intestinal infections].
    Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
    Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.